![Michal Reshef](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michal Reshef
Plus aucun poste en cours
Profil
Michal Reshef is the founder of Eqlibra Medical Systems Ltd.
She previously worked as the Preclinical Director at GeneGrafts Ltd.
Anciens postes connus de Michal Reshef
Sociétés | Poste | Fin |
---|---|---|
Eqlibra Medical Systems Ltd.
![]() Eqlibra Medical Systems Ltd. Medical SpecialtiesHealth Technology Eqlibra Medical Systems Ltd. develops miniature intravascular flow augmentation devices. It offers tiny retrievable pump, intended to improve blood flow in the coronary arteries after an angioplasty catheterization. Its customers include medical institutions and hospitals. The company was founded on September 01, 2007 and is headquartered in Kiryat Shmona, Israel. | Fondateur | - |
GeneGrafts Ltd.
![]() GeneGrafts Ltd. BiotechnologyHealth Technology GeneGrafts Ltd. develops proprietary technology for modulating excitable tissues. Its technology is used for the treatment of cardiac arrhythmias, Parkinson's disease and other neurological disorders. The company was founded by Yair Feld, Lior Gepstein, Shimon Marom and Meira Melamed Frank in 2003 and is headquartered in Haifa, Israel. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 2 |
---|---|
GeneGrafts Ltd.
![]() GeneGrafts Ltd. BiotechnologyHealth Technology GeneGrafts Ltd. develops proprietary technology for modulating excitable tissues. Its technology is used for the treatment of cardiac arrhythmias, Parkinson's disease and other neurological disorders. The company was founded by Yair Feld, Lior Gepstein, Shimon Marom and Meira Melamed Frank in 2003 and is headquartered in Haifa, Israel. | Health Technology |
Eqlibra Medical Systems Ltd.
![]() Eqlibra Medical Systems Ltd. Medical SpecialtiesHealth Technology Eqlibra Medical Systems Ltd. develops miniature intravascular flow augmentation devices. It offers tiny retrievable pump, intended to improve blood flow in the coronary arteries after an angioplasty catheterization. Its customers include medical institutions and hospitals. The company was founded on September 01, 2007 and is headquartered in Kiryat Shmona, Israel. | Health Technology |